Insilico signs US$888 million AI drug deal days after Hong Kong IPO
- Posted on January 5, 2026
- By South China Morning Post
- 4 Views
Insilico signs US$888 million AI drug deal days after Hong Kong IPO
Multi-year partnership with France’s Servier will use Insilico’s AI platform to explore novel cancer drugs.
